The disclosure references the company's previous letter (Ref no. ADL/SE/2026-27/56) dated October 28, 2026, which intimated about the conference call on financial results for the quarter and half year ended September 30, 2026.
The audio recording of the conference call has been uploaded on the company's website and is accessible at: https://www.aartidrugs.com/reports-fillings-concall-recording
The transcript of the conference call will be shared with both stock exchanges (BSE and NSE) and will also be uploaded on the company's website (https://www.aartidrugs.com) in due course.
